STOCK TITAN

Resideo Technologies Form 4 Filings

REZI NYSE

Every Form 4 that Resideo Technologies (REZI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow REZI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full REZI filings page.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. (REZI) reported that its Senior Vice President and Chief Financial Officer, Shane R. Harrison, received a grant of 51,203 shares of common stock on September 1, 2026. The award was acquired at a reported price of $0.00 per share and is held as direct ownership, bringing his directly held common shares to 51,203.

The filing indicates no Rule 10b5-1 trading plan for this transaction.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. executive Amit Ashvin Mehta, SVP, Strategy & Business Ops, reported an open-market purchase of 10,928.4 shares of common stock on 2026-08-17. The weighted average purchase price was $20.68 per share, with individual trades between $20.65 and $20.69. Following this transaction, Mehta directly holds 57,362.4 shares of Resideo common stock.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. executive Joshua Peter Foster, SVP, GC & Corp Sec, purchased 15,317 shares of common stock on 2026-08-14 in an open-market transaction. The weighted average purchase price was $20.58 per share, with individual trades between $20.44 and $20.63, increasing his direct holdings to 183,509 shares. The Rule 10b5-1 plan checkbox was not selected for this transaction.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. (REZI) reported that President and CEO Thomas A. Surran purchased 15,000 shares of common stock on 2026-08-14 in an open-market or private transaction. The weighted average purchase price was $20.46 per share, with individual trades between $20.41 and $20.47. Following this transaction, Surran directly holds 338,573 shares of Resideo common stock.

Rhea-AI Summary

Campelli Andrew reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies, Inc. reported that director Andrew Campelli received a grant of 6,407 restricted stock units (RSUs), each representing one share of common stock. The RSUs are scheduled to settle in shares on the earlier of August 13, 2027 or the company’s 2027 annual meeting of stockholders, subject to his continued service. According to the disclosure, Campelli holds these RSUs for the benefit of CD&R Channel Holdings, L.P. or an affiliate and is obligated to transfer the shares upon settlement, and therefore disclaims beneficial ownership of the reported securities. Following this award, 6,407 shares are reported as directly held in this capacity.

Rhea-AI Summary

SURRAN THOMAS A reported acquisition or exercise transactions in this Form 4 filing.

RESIDEO TECHNOLOGIES, INC. reported that President and CEO Thomas A. Surran received a grant of 45,125 shares of common stock on August 3, 2026, recorded as a non-derivative award at no per-share cost. Following this grant, his directly held common stock position is 323,573 shares.

Rhea-AI Summary

Resideo Technologies, Inc., which may be deemed a director and 10% owner of ADI Global Distribution Inc., reported restructuring transactions completed on August 3, 2026 in connection with the previously announced spin-off of ADI. ADI issued Resideo 75,918,198 shares of ADI common stock as part of internal reorganization steps, and Resideo then disposed of all 75,923,198 issued and outstanding ADI common shares by distributing a pro rata dividend of one ADI share for every two Resideo common shares held as of July 20, 2026, to effect the spin-off. Separately, ADI issued Resideo 150,000 shares of Series A Cumulative Convertible Participating Preferred Stock, initially convertible into ADI common stock at $16.152 per share and convertible at any time with no expiration; Resideo exchanged these ADI preferred shares for an equal number of its own Series A preferred shares held by other holders.

Rhea-AI Summary

CD&R Channel Holdings, L.P. exchanged 149,550 shares of Resideo Series A Cumulative Convertible Participating Preferred Stock in connection with a spin-off, disposing of these securities to the issuer. It continues to hold 348,950 Series A Preferred shares, now convertible into 18,517,830 common shares at an initial conversion price of $18.844 per share, adjusted from $26.92. The preferred is convertible at any time at the holder’s option, has no expiration, accrues dividends at 7.0% per annum (rising to 10.0% upon certain triggering events), and may be mandatorily converted if Resideo’s common stock trades above 200% of the then-effective conversion price for at least 20 of 30 trading days, subject to a lock-up.

Rhea-AI Summary

Resideo Technologies Chief Accounting Officer Jeffrey Kutz reported a routine tax-related share disposition. On July 7, 2026, 2,466 shares of common stock were withheld at $32.14 per share to satisfy tax obligations. After this transaction, he directly holds 36,332 common shares.

Rhea-AI Summary

Resideo Technologies director Andrew C. Teich reported a stock-based compensation award rather than an open-market trade. He acquired 4,834 stock units valued at $31.545 each under the 2018 Stock Plan for Non-Employee Directors, in lieu of his annual cash retainer fees.

The footnote explains these stock units are fully vested upon grant and will be settled in a lump sum of common shares after his service as a director ends. Following this award, his direct holdings stand at 359,676.631 shares of common stock.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. director Jack R. Lazar reported an acquisition of 1,010 common stock units on July 1, 2026. The units were granted at $31.545 per unit under the 2018 Stock Plan for Non-Employee Directors in lieu of annual cash retainer fees.

The stock units are fully vested upon grant and will be settled in a lump-sum issuance of common shares after his board service ends. Following this compensation-related grant, Lazar’s direct holdings are reported at 123,188 shares of common stock.

Rhea-AI Summary

DENINGER PAUL F reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies director Paul F. Deninger received a grant of 5,468 shares of Common Stock as compensation. The shares were awarded at no purchase price, reflecting a stock-based grant rather than an open-market transaction. Following this award, Deninger directly holds a total of 80,294 Resideo common shares.

Rhea-AI Summary

LAZAR JACK R reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies director Jack R. Lazar received a stock grant of 5,468 shares of Common Stock on June 3, 2026. The award was recorded at a price of $0.00 per share, indicating a compensation grant rather than a market purchase. After this grant, he directly holds 122,178 shares.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. director Andrew C. Teich received a grant of 5,468 shares of common stock on June 3, 2026 at no purchase price. This was reported as a non-derivative “grant, award, or other acquisition,” increasing his direct holdings to 354,842.631 shares.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. director Cynthia Lynn Hostetler reported an acquisition of company shares under a compensation grant. On June 3, 2026, she received 5,468 shares of Common Stock in a transaction classified as a “grant, award, or other acquisition,” at a reported price of $0.00 per share. After this award, her directly held position increased to 58,778 shares, according to the filing.

Rhea-AI Summary

Resideo Technologies director Sharon L. Wienbar received a grant of 5,468 shares of Common Stock on June 3, 2026. The award was recorded at a price of $0.00 per share, indicating a compensation-related stock grant rather than a market purchase. Following this grant, Wienbar directly holds a total of 86,023 Resideo common shares. The filing shows no sales or option exercises, only this single equity award increasing her direct ownership stake.

Rhea-AI Summary

Yusuf Kareem reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies director Yusuf Kareem received an equity award of 5,468 shares of Common Stock on June 3, 2026. The shares were granted at no cash cost per share as compensation rather than an open-market purchase. Following this award, Kareem directly holds 41,403 common shares of Resideo Technologies.

Rhea-AI Summary

Kushner Brian reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies director Brian Kushner reported an equity grant of 5,468 shares of common stock on June 3, 2026. The shares were awarded at a stated price of $0.00 per share, reflecting a compensation-related grant rather than a market purchase. After this award, Kushner directly holds 70,039 common shares.

Rhea-AI Summary

Richardson Nina reported acquisition or exercise transactions in this Form 4 filing.

RESIDEO TECHNOLOGIES, INC. director Nina Richardson reported receiving a grant of 5,468 shares of common stock on June 3, 2026. The shares were awarded at a stated price of $0.00 per share, indicating compensation rather than an open-market purchase. After this award, she directly holds 63,354 common shares, reflecting a routine equity grant for board service rather than a buy or sell transaction.

Rhea-AI Summary

Resideo Technologies director John S. Stroup reported an award of 5,468 restricted stock units (RSUs) tied to the company’s common stock. Each RSU will convert into one share of common stock on the earlier of June 3, 2027 or the company’s 2027 annual stockholder meeting, if he continues in service through that date.

The RSUs are held for the benefit of CD&R Channel Holdings, L.P. or an affiliate, and any shares issued on settlement must be transferred to that entity. Stroup therefore disclaims beneficial ownership of these securities.

Rhea-AI Summary

Sleeper Nathan K reported acquisition or exercise transactions in this Form 4 filing.

RESIDEO TECHNOLOGIES, INC. director Nathan K. Sleeper reported the grant of 5,468 restricted stock units tied to the company’s common stock. These RSUs are scheduled to settle in shares on the earlier of June 3, 2027 or the issuer’s 2027 annual meeting of stockholders, subject to his continued service. Under the disclosed arrangement, Sleeper holds these RSUs for the benefit of CD&R Channel Holdings, L.P. or an affiliate, is obligated to transfer any shares received in settlement to that entity, and therefore disclaims beneficial ownership of the reported securities.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. Chief Financial Officer Michael Carlet reported a routine tax-related share disposition. On this Form 4, 1,944 shares of Common Stock were withheld at $29.22 per share to satisfy tax liabilities, rather than being sold in the open market.

Following this tax-withholding disposition, Carlet directly holds 166,706 shares of Common Stock. A footnote also clarifies that his earlier Form 3 filing had understated his direct holdings by 100 shares, correcting his reported ownership history.

Rhea-AI Summary

RESIDEO TECHNOLOGIES director Nina Richardson reported an open-market sale of 2,789 shares of Common Stock on August 12, 2025 at $29.67 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 27, 2024, and she now holds 57,886 shares directly.

Rhea-AI Summary

TEICH ANDREW C reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies director Andrew C. Teich received an equity award rather than making an open-market trade. On the grant date, he was awarded 4,442 stock units tied to Common Stock, valued at $34.33 per share, under the 2018 Stock Plan for Non-Employee Directors.

The footnote explains these stock units were issued in lieu of annual cash retainer fees, are fully vested upon grant, and will be settled in a lump-sum issuance of shares of Common Stock after his service as a director ends. Following this grant, his directly held Common Stock and related units total 349,374.631 shares.

Rhea-AI Summary

LAZAR JACK R reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies director Jack R. Lazar received a grant of 928 stock units of Common Stock valued at $34.33 per unit under the company’s 2018 Stock Plan for Non-Employee Directors, issued in lieu of his annual cash retainer. These units are fully vested on grant and will be settled in a lump-sum share issuance after his board service ends. Following this award, he directly holds 116,710 shares of Common Stock.

Rhea-AI Summary

Geldmacher Jay L reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies President and CEO Jay L. Geldmacher received a grant of 82,530 shares of common stock on February 18, 2026 at a stated price of $0.00 per share. Following this equity award, his directly owned common stock holdings increased to 849,645 shares.

Rhea-AI Summary

Kutz Jeffrey reported acquisition or exercise transactions in this Form 4 filing.

Resideo Technologies reported that Chief Accounting Officer Jeffrey Kutz received a grant of common stock. On this Form 4, he was awarded 11,828 shares of Resideo common stock at a price of $0.00 per share as a grant or award. Following this award, his directly held stake increased to 38,798 common shares.

Rhea-AI Summary

Resideo Technologies President and CEO Jay L. Geldmacher reported a grant of 504,466 shares of common stock on February 13 as a stock award at $0.00 per share. On February 13–15, shares were disposed of as tax-withholding transactions at $35.985 per share, leaving him with 767,115 directly owned shares after the last transaction.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. executive Jeannine J Lane, EVP, General Counsel and Corporate Secretary, reported multiple equity transactions in company common stock. On February 13, she received stock grants of 20,873 shares and 68,312 shares at a stated price of $0.00 per share.

To cover tax obligations, she reported tax-withholding dispositions of 5,879 shares at $36.285 on February 12, and 34,874 and 5,813 shares at $35.985 on February 13 and February 14. After the most recent transaction, she directly held 218,423 shares, which include 523 shares acquired through the employee stock purchase plan.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. executive Thomas A. Surran, President Products & Solutions, reported two stock transactions. On February 13, 2026, he acquired 30,615 shares of common stock as a grant or award at $0.00 per share. On February 12, 2026, he disposed of 7,096 shares at $36.285 per share to cover taxes through share withholding. After these transactions, he directly owns 278,448 common shares.

Rhea-AI Summary

Resideo Technologies EVP and Chief HR Officer Stephen Kelly Montgomery reported multiple stock transactions involving company common shares. On February 13, he received two stock awards totaling 63,680 shares at no cost as equity compensation. Around the same time on February 12, 13 and 14, a total of 22,612 shares were disposed of to cover tax withholding obligations at prices around $36 per share, rather than through open-market selling. After these transactions, he directly owned 307,929 common shares, which includes 461 shares acquired through the employee stock purchase plan.

Rhea-AI Summary

RESIDEO TECHNOLOGIES, INC. President, ADI, Robert B. Aarnes reported a mix of stock grants and tax-related share dispositions in common stock. On February 13, 2026, he acquired 30,615 and 115,606 shares as grants at $0.0000 per share. On February 12–14, 2026, he disposed of 6,646, 45,491, and 7,582 shares at prices of $36.2850 and $35.9850 per share to cover tax liabilities through share withholding, not open-market sales. After these transactions, his direct holdings were 561,875 shares of common stock.

Rhea-AI Summary

Resideo Technologies Chief Financial Officer Michael Carlet reported routine equity compensation transactions. He received a grant of 27,831 shares of common stock on February 13, 2026, then had 10,862 shares and 4,613 shares withheld on February 15 and February 12, 2026 to cover tax obligations. He now directly owns 168,550 common shares.

Rhea-AI Summary

Resideo Technologies officer Thomas A. Surran, President Products & Solutions, reported a disposition of common stock. On February 5, 2026, a transaction in 6,944 shares of common stock was filed with transaction code "F" at a price of $35.26 per share. Following this transaction, Surran directly beneficially owned 254,929 shares of Resideo Technologies common stock.

Rhea-AI Summary

Resideo Technologies executive Jeannine J. Lane, EVP, General Counsel and Corporate Secretary, reported a disposition of 6,708 shares of common stock on February 5, 2026, recorded with transaction code F at a price of $35.26 per share. After this transaction, she directly beneficially owned 175,281 common shares of Resideo Technologies.

Rhea-AI Summary

Resideo Technologies officer reports stock disposition. A Form 4 filing shows that Robert B. Aarnes, President of ADI at Resideo Technologies, Inc., recorded a transaction in common stock on February 5, 2026. He disposed of 8,644 shares at a price of $35.26 per share and now holds 475,373 common shares directly.

Rhea-AI Summary

Resideo Technologies executive Stephen Montgomery Kelly, EVP and Chief HR Officer, reported a disposition of company common stock. On February 5, 2026, a transaction coded "F" involved 2,602 shares of Resideo common stock at $35.26 per share. After this transaction, Kelly beneficially owned 266,400 common shares, held directly.

Rhea-AI Summary

Resideo Technologies director equity grant: Director Andrew C. Teich reported receiving 4,312 shares of Resideo Technologies, Inc. common stock on 01/01/2026. The shares are valued at $35.36 per share and were issued under the 2018 Stock Plan for Non-Employee Directors in lieu of annual cash retainer fees. After this grant, he beneficially owns 344,932.631 shares of common stock on a direct basis. The related stock units are fully vested upon grant and are designed to be settled in a lump sum of common shares after his service as a director ends.

Rhea-AI Summary

Resideo Technologies director Jack R. Lazar reported receiving an equity grant of 901 shares of common stock effective 01/01/2026 at a price of $35.36 per share. This was issued under the company’s 2018 Stock Plan for Non-Employee Directors in lieu of annual cash retainer fees. The stock units are fully vested upon grant and will be settled in a lump sum of common shares after his service as a director ends. Following this grant, Lazar beneficially owns 115,782 shares of Resideo common stock directly.

Rhea-AI Summary

Resideo Technologies officer reports stock disposition. A company officer, identified as President, ADI, reported disposing of 19,675 shares of Resideo Technologies common stock on 12/14/2025 at a price of $35.925 per share. After this transaction, the reporting person directly beneficially owns 484,017 shares. The report is filed on Form 4 for a single reporting person in connection with this insider equity transaction.

Rhea-AI Summary

Resideo Technologies executive Jeannine J. Lane, EVP, General Counsel and Corporate Secretary, reported an option exercise and related share withholding. On 12/10/2025, she exercised a fully vested stock option to buy 76,109 shares of Resideo common stock at an exercise price of $10.27 per share. To cover the option exercise price and tax withholding obligations, 49,678 shares were withheld by the company at a price of $35.35 per share. Following these transactions, Lane directly beneficially owned 181,989 shares of Resideo common stock, including 422 shares acquired through the company’s employee stock purchase plan.

Rhea-AI Summary

Resideo Technologies EVP and Chief HR Officer Kelly Stephen Montgomery exercised stock options covering 81,818 shares of common stock at an exercise price of $10.27 per share on December 10, 2025. In connection with this exercise, 46,612 shares were withheld by the issuer to satisfy the exercise price and tax obligations at $35.35 per share. After these transactions, he directly owns 269,002 shares of Resideo common stock.

Rhea-AI Summary

Resideo Technologies, Inc. insider activity: Thomas A. Surran, an officer serving as President Products & Solutions, reported a disposition of 4,887 shares of Resideo common stock on 12/05/2025. The shares were reported as disposed of at a price of $34.13 per share under transaction code "F," which typically indicates shares withheld in connection with an equity-related obligation.

Following this transaction, Surran reported beneficial ownership of 261,873 shares of Resideo common stock held directly. The filing indicates it was made by a single reporting person and was signed by an attorney-in-fact on Surran’s behalf.

Rhea-AI Summary

Resideo Technologies Chief Financial Officer Michael Carlet reported a Form 4 transaction involving company common stock. On 11/15/2025, he disposed of 2,333 shares of Resideo common stock at a price of $32.08 per share, reported under transaction code F. After this transaction, he beneficially owns 156,194 shares of Resideo common stock in direct ownership.

Rhea-AI Summary

Resideo Technologies (REZI) reported insider buying by CD&R Channel Holdings II, L.P., identified as a director and 10% owner. The Form 4 lists five open‑market purchases between November 10–13, 2025 at weighted average prices ranging from $30.5438 to $32.0788. Trades included 333,000, 390,000, 400,000, 278,939, and 287,819 shares, coded “P” for purchases. Following these transactions, the reporting person beneficially owned 14,960,492 shares, held directly. Footnotes note weighted-average pricing across multiple executions and clarify the CD&R ownership structure and disclaimers.

Rhea-AI Summary

Resideo Technologies (REZI) reported an insider purchase by director Andrew C. Teich. On 11/10/2025, he bought 8,148.631 shares of common stock at a weighted average price of $30.677, with individual trades ranging from $30.67 to $30.68.

Following the transaction, Teich beneficially owns 340,620.631 shares, held directly. The footnote states he will provide full trade-by-trade details upon request.

Rhea-AI Summary

Jack R. Lazar, a director of Resideo Technologies, Inc. (REZI), received 747 shares of Common Stock on 10/01/2025 as stock units issued under the company’s 2018 Stock Plan for Non-Employee Directors in lieu of an annual cash retainer. The reported acquisition lists a per‑share price of $42.675 and shows 114,881 shares beneficially owned following the transaction. The stock units are fully vested upon grant and are to be settled by issuance of shares in a lump sum following termination of director service. The Form 4 was signed by an attorney‑in‑fact on 10/03/2025.